30% overturnedAppeal outcomes · Laboratory

Denied laboratory testing: what independent reviewers actually decided

Laboratory denials were upheld more often than any other service in this corpus, and the minority that fell shared one trait.

Pathology and clinical laboratory studies ordered by the treating physician and denied at prior authorization or on the claim — the highest-volume denial category a practice sees, and the one payers gate most mechanically.

What the independent reviewers decided

30%

overturned by the independent reviewer

199

of 674 decisions in the corpus

Source

California DMHC independent medical review determinations, 2017-2026. Public record.

Read this as a base rate, not as your odds

These are decisions about other patients, in one state, that had already been through the plan's own internal appeal and were then sent to an outside reviewer. That population is self-selected toward disputes worth pursuing, so the rate says what happened to cases like this at that stage — not what will happen to a specific claim. It is not medical or legal advice.

Why plans deny laboratory testing

  • The policy treats the panel as screening where it covers the test only for a defined indication.
  • Frequency limits: the same study falls inside an interval the policy restricts.
  • The diagnosis submitted does not appear on the policy's covered-indication list for that assay.
  • The test is characterised as not established for the clinical question being asked.

What actually carried the cases that won

Guideline support led here, and that ordering is the whole lesson. Elsewhere in this corpus a patient's own treatment history decided the case; laboratory appeals were decided by whether a recognised guideline puts the test where the physician put it. The reversals named the guideline and the indication it covers. Clinical guidelines were the authority reviewers reached for most, ahead of the literature — the reverse of the injection and infusion groups.

What the record showedShare of overturned decisions
A published guideline supported the request49%
Objective findings were documented39%
The diagnosis was confirmed20%
The condition was documented as chronic or long-standing12%
The severity or urgency was documented8%
Prior treatment was documented5%
The functional impact on the patient was documented5%
Conservative treatment was documented as failed3%

Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.

What the reviewers cited

  • Clinical guidelines — in 38% of the overturned decisions
  • Peer-reviewed literature — in 28% of the overturned decisions
  • Specialty-society criteria — in 25% of the overturned decisions
  • Standard of care — in 17% of the overturned decisions
  • FDA labeling — in 5% of the overturned decisions

laboratory testing denials — frequently asked

Is a denied lab test worth appealing?
California reviewers overturned 199 of the 674 laboratory disputes they decided — 30%, the lowest share of any service in this corpus. Lab denials survived neutral review better than anything else we track, which is worth weighing before spending a practice's time on one.
What makes a laboratory appeal succeed?
A named guideline. Guideline support appeared in 49% of the reversals, ahead of the patient's own findings, and clinical guidelines were the authority reviewers cited most. Pointing at the specific recommendation that covers this indication is the argument these decisions were made on.
Are frequency denials different?
They turn on what changed. Where a policy restricts the interval, the reversals showed a new finding, a new symptom or a treatment change since the last study rather than arguing the interval was unreasonable.

Related guides

CO-50 — not medically necessaryCO-16 — missing or invalid informationHow external review works

Source

Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.

Appeal a denial →